Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
REGENXBIO
Biotech
RegenXBio sells Hunter syndrome gene therapy commercial rights
With an FDA approval submission for RegenXBio’s Hunter syndrome gene therapy already underway, the biopharma has found a commercialization partner.
James Waldron
Jan 14, 2025 5:56am
Regenxbio starts pivotal study for DMD gene therapy
Nov 18, 2024 2:24pm
J&J, Bayer, Santa Ana, Regenxbio and more—Chutes & Ladders
Jun 14, 2024 8:30am
Adverum's gene therapy reduces treatment burden in wet AMD
Feb 8, 2024 11:17am
Regenxbio-AbbVie in-office gene therapy clears phase 2 test
Jan 17, 2024 9:42am
SQZ lays off 80% of staff, Regenxbio cuts 15%
Nov 9, 2023 8:23am